NCT07441057 Effects of CHRIST on Upper Limb Function in Children With Pediatric Stroke
| NCT ID | NCT07441057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-02-04 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pediatric stroke poses significant challenges due to its impact on a child's developing brain. Both ischemic and hemorrhagic strokes in children can result in long-term motor, sensory, and cognitive impairments, particularly affecting upper limb function. Comprehensive Hand Repetitive Intensive Strength Training is a structured intervention model that integrates high-repetition, strength-based, and goal-oriented exercises targeting upper limb coordination and use. This study aims to explore the efficacy of CHRIST in improving upper limb function using the ABILHAND-Kids questionnaire to assess changes in manual ability. The study aims to generate pediatric-specific evidence for intensive hand-focused rehabilitation strategies.
Eligibility Criteria
Inclusion Criteria: * Children aged 7 to 12 years diagnosed with pediatric ischemic or hemorrhagic stroke(21). * Clinical evidence of upper limb motor impairment following stroke. * Parent/guardian consent and child assent obtained. Exclusion Criteria: * Severe cognitive or behavioral impairments interfering with therapy. * Uncontrolled seizures or medical conditions contraindicating exercise. * Previous participation in intensive upper limb therapy within the last 3 months. * Orthopedic conditions (e.g., fractures, contractures) that limit upper limb movement.
Contact & Investigator
Mashar Hayat, MS
PRINCIPAL INVESTIGATOR
Riphah International University, Lahore
Frequently Asked Questions
Who can join the NCT07441057 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 12 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07441057 currently recruiting?
Yes, NCT07441057 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07441057 trial being conducted?
This trial is being conducted at Mandi Bahāuddīn, Pakistan.
Who is sponsoring the NCT07441057 clinical trial?
NCT07441057 is sponsored by Riphah International University. The principal investigator is Mashar Hayat, MS at Riphah International University, Lahore. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.